Advertisement
Advertisement
U.S. Markets open in 4 hrs 12 mins
Advertisement
Advertisement
Advertisement
Advertisement

Sabra Health Care REIT, Inc. (SBRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.81+0.63 (+4.15%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/9/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.33
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 317.15
52 Week Low 311.44
50-Day Moving Average 314.39
200-Day Moving Average 313.79

Share Statistics

Avg Vol (3 month) 32.23M
Avg Vol (10 day) 31.7M
Shares Outstanding 5228.68M
Implied Shares Outstanding 6N/A
Float 8228.05M
% Held by Insiders 11.27%
% Held by Institutions 188.85%
Shares Short (Jul 14, 2022) 413.5M
Short Ratio (Jul 14, 2022) 45.54
Short % of Float (Jul 14, 2022) 48.42%
Short % of Shares Outstanding (Jul 14, 2022) 45.85%
Shares Short (prior month Jun 14, 2022) 413.16M

Dividends & Splits

Forward Annual Dividend Rate 41.2
Forward Annual Dividend Yield 47.85%
Trailing Annual Dividend Rate 31.20
Trailing Annual Dividend Yield 37.91%
5 Year Average Dividend Yield 48.96
Payout Ratio 4N/A
Dividend Date 3Aug 30, 2022
Ex-Dividend Date 4May 12, 2022
Last Split Factor 21:3
Last Split Date 3Nov 15, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -26.45%
Operating Margin (ttm)10.23%

Management Effectiveness

Return on Assets (ttm)0.43%
Return on Equity (ttm)-3.09%

Income Statement

Revenue (ttm)401.18M
Revenue Per Share (ttm)1.79
Quarterly Revenue Growth (yoy)8.80%
Gross Profit (ttm)246.6M
EBITDA 234.45M
Net Income Avi to Common (ttm)-106.1M
Diluted EPS (ttm)-0.24
Quarterly Earnings Growth (yoy)21.40%

Balance Sheet

Total Cash (mrq)34.34M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)2.36B
Total Debt/Equity (mrq)70.13
Current Ratio (mrq)1.83
Book Value Per Share (mrq)15.07

Cash Flow Statement

Operating Cash Flow (ttm)350.97M
Levered Free Cash Flow (ttm)201.96M
Advertisement
Advertisement